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The eﬀect of intracerebroventricular (ICV) antileptin antibody on the onset of puberty in the female rat and the relationship
between serum leptin, luteinizing hormone (LH), and body weight were investigated. Antileptin antibody (group A) was infused
ICV from days 23–36 in prepubertal female rats whereas the control (group B) received ICV goat immunoglobulin G (IgG). In the
antileptin group, mean day of vaginal opening (VO) was postponed (day 34 versus day 30, P<. 01 ). Body weight trended higher
after 30 days in the antileptin group but not signiﬁcantly. However, there was no diﬀerence in serum leptin and LH between the
two groups on the day of VO. Serum leptin was relatively constant from day 23 through day 31 and did not correlate with LH
(r = 0.14,P = .10). These studies demonstrate that central leptin promotes the onset of female rat puberty as evidenced by VO.
Finally, central leptin impacts female rat pubertal onset in distinction from serum leptin and body weight.
Copyright © 2009 Ruimin Chen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
It is well recognized that a requisite for the onset of human
puberty is a healthy body composition, particularly a critical
mass of body fat [1, 2]. Low body fat prevents or hinders the
onset of puberty [3, 4]. For decades it has beenproposed that
aperipheralmetabolicsignalfromadiposetissueoverseesthe
onset of puberty. Leptin, an adipocyte hormone and product
of the obese (ob) gene, may be a primary candidate signal
molecule among other complex metabolic signals [1].
In humans, leptin correlates most signiﬁcantly with
BMI and body fat [5]. Numerous studies have inferred
that leptin may regulate the hypothalamic-pituitary-gonadal
axis. One indication that leptin is involved in centrally
regulated maturation of the reproductive system was the
discoverythat ob/ob femalesare alwayssterile [6], and weight
loss induced by dietary restriction fails to correct their
sterility. Importantly, their fertility can be reversed by leptin
treatment in both sexes [7, 8]. The ob/ob leptin deﬁcient and
db/db leptin resistant mouse models have greatly advance
our understanding regarding the pivotal role of leptin in
reproduction [9, 10]. Moreover, the ability of leptin to
accelerate the onset of puberty in normal female mice has
been demonstrated [9].
In vitro and in vivo studies demonstrated an acute
stimulatory eﬀect of leptin on the hypothalamic-pituitary
unit in adult rats [11]. Exogenous leptin produced a
dose-related increase in follicle-stimulating hormone (FSH)
and luteinizing hormone (LH) release in healthy rats and
isolated pituitary cells [11, 12]. Furthermore, leptin can
increase the hypothalamic gonadotropin-releasing hormone
(GnRH) content at 15 days of age in female rats [13].
In agreement with this ﬁnding, studies in healthy mice
demonstrated premature puberty after intraperitoneal leptin
administration [14]. However, in another study concerning
male rats, no correlation between simultaneous leptin and
LH measurements was reported; the implication of this is
that leptin does not modify puberty by direct actions on the
hypothalamic-pituitary axis [15].2 International Journal of Pediatric Endocrinology
In short, the issue as to the role of leptin in the regulation
of puberty is controversial. Also, conﬂicting data exists as
to whether serum leptin concentrations increase temporarily
during puberty in female. Moreover, the precise relationship
between leptin and LH secretion in female rats through the
prepubertal and peripubertal period has not been deﬁned.
To address the issue, we infused antileptin antibody
(experimental group A) versus IgG (control group B) in
prepubertal female rats and monitored the time to puberty
onset,asdeterminedbyvaginalopening(VO)andsequential
serum LH and leptin concentrations.
2. Methods
2.1. Animals. 21 Sprague-Dawley females rats, age 21 days
and body weight 50 ± 6g, were studied. All rats were born
at the Shanghai Animals Institute. Rats were housed in
ar o o ma t2 3
◦ with a 12/12 light/dark cycle. Starting on
postnatal day 23, all animals were allowed free access to a
standard laboratory rat chow and water. All of the following
procedures were approved by the Fujian Medical University
Animal Care and Use Committee (Fujian, China).
2.2. Immunoglobulins and Protein Assay. Protein was mea-
sured by a Coomassie Blue G-250 dye-binding assay. Goat-
derived antirat leptin and normal goat IgG were purchased
from Pepro Tech (Rocky Hill, NJ, USA) and diluted to
0.1μg/μL solution.
2.3. Intracerebroventricular Surgery. At 23 days of age, rats
were randomly divided into antileptin antibody treated
group A and control groups B, the latter receiving goat IgG.
After pentobarbital anesthesia, all rats were implanted with
a stainless steel cannula positioned stereotaxically into the
left lateral ventricle of the brain via a hole drilled in the
skull (1.3mm lateral and 1.3mm posterior to bregma), and
the cannula was ﬁxed at a depth of 4.0mm from the skull
surface.
Postoperatively, the health status of the rats was moni-
tored several times daily.
2.4. Experimental Groups and Procedure. F r o md a y2 3t od a y
36, group A (n = 10) and B rats (n = 11) were injected
ICV daily either with 6uL antileptin antibody (group A) or
equivolume goat IgG (group B).
Body weights were measured every other day and VO
was monitored two times per day at 9 AM and 9 PM. Blood
samples were obtained at 9 AM via a tail vein on every other
d a yf r o md a y s2 3t o3 9 .
The last blood sample was obtained on postnatal day
39. To conﬁrm the cannula placement, on day 43 all rats
were injected with a dye (Evans blue). Only those rats
with the cannula positioned correctly in the lateral ventricle
of the brain were included in the analysis. Before VO,
one rat died during surgery in control, group B, and two
rats in the antileptin, group A died. The two later rats
(group A) appeared vigorous until death. No cause was
identiﬁed.
2.5. Hormonal Assays. Leptin and LH blood samples were
obtained at 9 AM every other day via tail vein. Serum was
frozen at −20
◦ until assayed for leptin and LH content.
2.6. Hormone and Metabolite Determinations. Serum was
assayed for leptin using ELISA kit from Linco Research Inc.
(St Charles, Mo, USA). Serum was assayed for LH using
ELISA kits from Shanghai Lan Dun Inc. The sensitivities of
the LH and leptin assays were 0.04ng/mL and 0.01ng/mL,
respectively. The inter- and intra-assay coeﬃcients of varia-
tions were both less than 10% for both assays.
2.7. Statistical Analysis. Results are expressed as the mean ±
SEM. T-tests (and nonparametric test) was used to analyze
the data. The median day of VO is also given. Statistical
correlations between serum leptin and LH were determined
using the Pearson Product-Moment Correlation Coeﬃcient.
Diﬀerences were considered signiﬁcant if P w a sl e s st h a n. 0 5 .
3. Results
As illustrated in Figure 1, throughout the study the body
weights in both groups were similar (P>. 05). While a
slight deviation in weight gain was suggested after 35 days,
these weight diﬀerences were not signiﬁcant and, moreover,
barely apparent between 30 and 34 days. Notably, the body
weight on the day of VO in the antileptin antibody group
was not signiﬁcantly higher compared to the control group B
(Figure 1). The rats that received antileptin antibody (group
A) had a signiﬁcant (P<. 01) delay in VO (mean ± SEM VO
group A = 34 ± 1d a y sv e r s u s3 0 . 2± 0.7 days in the control
group B). The median VO in group A was 33 days (range 30–
39) versus a median VO of 30 days (range 27–34), control
group B.
Figure 2 depicts serum leptin during sexual maturity
after central antileptin antibody infusion. Serum concen-
trations of leptin were relatively constant from day 23
through day 31. Nevertheless, at day 35, day 37, and day
39, there was a statistically signiﬁcant increase in leptin
concentrations in antileptin group A compared to the start
day(day23).Thisincreasedidnotoccurinthecontrolgroup
B. Unexplained also, a signiﬁcant (P<. 0001) depression
in serum leptin occurred on day 33 in antileptin group
A.
The LH data, illustrated in Figure 3, revealed that both
the antileptin treated group A and control group B had,
when compared to the beginning of the experiment (day 23),
signiﬁcant increases in the serum LH concentrations from
days 27 through 39 or from days 29 through 39, respectively.
There was no signiﬁcant diﬀerence in serum LH between the
two groups on the same chronological day of age at any time
point examined.
Finally, there was no signiﬁcant correlation between
serum leptin and LH (r = 0.14, P = .10) throughout the
study period (data not shown).International Journal of Pediatric Endocrinology 3
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Figure 1:Bodyweightasratsapproachandduringpuberty(n = 10
in antileptin group A, and n = 11 in control group B). Data are
expressed as mean ± SEM. Arrows indicate the mean day of VO
in each group (antileptin group A = 34 ± 1d a y sv e r s u s3 0 .2 ± 0.7
days in the control group B (P<. 01). Median VO data are given
in the results. No diﬀerence in body weight (P>. 05) was observed
between the two groups.
4. Discussion
By using normal healthy female rats, this study examined
the eﬀect of ICV antileptin antibody on the onset of rat
puberty and circulating levels of leptin and LH. Remarkably,
which one of the several biochemical trigger(s) or perhaps
combinations thereof, governs the onset of puberty remains
unproven [10, 16, 17]. The role of leptin in puberty is
inferred in leptin receptor-deﬁcient patients who have an
associated hypogonadotropic hypogonadism [18, 19].
These adduced studies suggest that leptin may be a
requisite metabolic signal necessary for the initiation of
pubertal development. In the female rat, vaginal opening
provides a reliable and conspicuous external sign for the
onset of this process. In our studies, antileptin antibody
administrated to group A was able to signiﬁcantly postpone
VO compared to control group B (P<. 01). Furthermore, as
in the control group, serum leptin in group A was relatively
constant from day 23 through day 31. A previous study
likewisereporteddelayedVOinratsfollowingICVantileptin
antibody, the extent of the delay depending on the feeding
protocol of the rats [20].
Circulating leptin levels have been measured during
pubertal development in several species. In female mice,
a peak in plasma levels of leptin during the second week
of postnatal life has been noted to occur independently of
changes in body weight and prior to increases in estradiol.
A signiﬁcant elevation of plasma leptin during the peripu-
bertal period was not observed [21]. Likewise, no change
was detected in circulating daytime leptin in male rhesus
macaques over the peripubertal period, during which time
LH, FSH, and testosterone levels were approaching adult
levels [22]. Similarly, female rats that underwent central
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Figure 2: Serum leptin concentrations as rats approach and during
puberty (n = 10 in antileptin group A and n = 11 in control group
B).Dataarepresentedasmean ±SEM.Fromday23throughday31,
no diﬀerence in leptin was observed between the two groups (P>
.05). Nevertheless, at days 35, 37, and 39, there was a statistically
signiﬁcant increase compared to day 23 in group A (P = .013, .004,
.001, resp.). For the control group of all ages, this rise in serum
leptin did not occur (P>. 05). Arrows indicate the mean day of
VO (see Figure 1 legend for details).
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Figure 3: Serum LH concentrations as rats approach and during
puberty (n = 10 in antileptin group A and n = 11 in control group
B). Data is presented as mean ± SEM (P>. 05 for all ages). Arrows
indicate the mean day of VO (see Figure 1 legend for details).
immunoneutralization of leptin, as in our experiments, had
no signiﬁcant change in circulating leptin compared to IgG
ICV-treated controls [20].
In our studies, at day 35, day 37, and day 39, there
were statistically signiﬁcant increases compared to day 23 in
the serum leptin concentrations in group A rats. Seemingly,
serum leptin rebounded in antileptin group A after day
35, however, this was not observed in the control group B4 International Journal of Pediatric Endocrinology
rats. Tellingly, the body weight on the day of VO in the
antileptin treated group was signiﬁcantly higher compared
with that of control group, implying that central leptin is
more relevant than body weight in initiating puberty. Also,
administration of leptin to female mice (intraperitoneal) or
rat (ICV) induced early onset puberty despite attenuated
weight gain [14, 23].
Peripheral leptin treatment produces central modulation
of GnRH secretion and alters LH pulse frequency in food
restricted animals [16] .F o rl e p t i nt ob ea c t i v e l yi n v o l v e d
in initiating puberty, it should act centrally to modify LH
release. Serum levels of LH can serve as an indirect measure
of hypothalamic function [11]. Nevertheless, in our rats,
serum leptin did not signiﬁcantly correlate with serum LH.
Hiney et al. reported that leptin replacement was able to
reversethesuppressedlevelsofLHcausedbyethanol,butthe
onset of puberty was still delayed [24]. These results buttress
our ﬁndings that LH is not the sole hormone which initiates
puberty [25, 26].
The lack of correlation between serum leptin and LH
(usingourassaymethods)suggeststhatcirculatingleptinper
se does not aﬀect gonadotropin secretion. However, leptin
given intraperitoneal reportedly prevents the reduction in
LH pulse frequency induced by fasting [16]. Nonetheless,
central leptin is a likely modiﬁer of the gonadotropin axis
[27]. This supports our ﬁnding that there was no diﬀerence
in circulating leptin or LH levels by our assay method
between the two groups.
Almost certainly, VO is determined by ovarian estrogen
production. Because serum leptin and LH were not diﬀerent
between the two groups, yet VO was aﬀected by central
antileptin, this raises the possibility of other factors alter
gonadal hormone production.
One possibility is that leptin oversees GnRH secretion
by acting transynaptically [10]. Yet another mechanistic
scenario is that leptin serves to regulate an unknown inter-
mediate which in turn control GnRH [28]. The molecular
mechanismandsiteofaction,wherebycentralleptingoverns
the onset of puberty of female rat remain unresolved.
We conclude that central leptin, in contrast to that in the
periphery, plays a key role in female rat puberty and more
so than body mass or serum LH. Finally, central leptin, not
serum leptin, may be more germane than body weight on
impacting female rat puberty.
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